Tocilizumab for systemic sclerosis: implications for future trials

Distler O, Distler J (2016)

Publication Type: Journal article, other

Publication year: 2016

Journal

The Lancet Elsevier

Book Volume: 387

Pages Range: 2580-1

Journal Issue: 10038

DOI: 10.1016/S0140-6736(16)00622-X

Authors with CRIS profile

Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

Universitätsspital Zürich (USZ) CH Switzerland (CH)

How to cite

APA:

Distler, O., & Distler, J. (2016). Tocilizumab for systemic sclerosis: implications for future trials. The Lancet, 387(10038), 2580-1. https://doi.org/10.1016/S0140-6736(16)00622-X

MLA:

Distler, Oliver, and Jörg Distler. "Tocilizumab for systemic sclerosis: implications for future trials." The Lancet 387.10038 (2016): 2580-1.

BibTeX: Download